These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30034913)

  • 1. Targeting the gut barrier for the treatment of alcoholic liver disease.
    Zhou Z; Zhong W
    Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Hong M; Han DH; Hong J; Kim DJ; Suk KT
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease.
    Chen L; Zhu Y; Hou X; Yang L; Chu H
    Front Med (Lausanne); 2022; 9():840752. PubMed ID: 35308525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota, a key player in alcoholic liver disease.
    Cassard AM; Ciocan D
    Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.
    An L; Wirth U; Koch D; Schirren M; Drefs M; Koliogiannis D; Nieß H; Andrassy J; Guba M; Bazhin AV; Werner J; Kühn F
    J Gastrointest Surg; 2022 Mar; 26(3):671-683. PubMed ID: 34734369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier.
    Liu H; Kang X; Yang X; Yang H; Kuang X; Ren P; Yan H; Shen X; Kang Y; Li L; Wang X; Guo L; Tong M; Fan W
    Probiotics Antimicrob Proteins; 2023 Feb; 15(1):185-201. PubMed ID: 36456838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
    Jung JH; Kim SE; Suk KT; Kim DJ
    Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-based treatments in alcoholic liver disease.
    Sung H; Kim SW; Hong M; Suk KT
    World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Ranjbarian T; Schnabl B
    Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionate Ameliorates Alcohol-Induced Liver Injury in Mice via the Gut-Liver Axis: Focus on the Improvement of Intestinal Permeability.
    Xu Q; Zhang R; Mu Y; Song Y; Hao N; Wei Y; Wang Q; Mackay CR
    J Agric Food Chem; 2022 May; 70(20):6084-6096. PubMed ID: 35549256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stearic acid prevent alcohol-induced liver damage by regulating the gut microbiota.
    Nie W; Xu F; Zhou K; Yang X; Zhou H; Xu B
    Food Res Int; 2022 May; 155():111095. PubMed ID: 35400467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome dysbiosis and alcoholic liver disease
    Li F; McClain CJ; Feng W
    Liver Res; 2019 Dec; 3(3-4):218-226. PubMed ID: 33868760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy.
    Subramaniyan V; Chakravarthi S; Jegasothy R; Seng WY; Fuloria NK; Fuloria S; Hazarika I; Das A
    Toxicol Rep; 2021; 8():376-385. PubMed ID: 33680863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.